This job opening is also posted on NYU Langone’s job portal as Senior Research Technician (1129021_RR00092524).
Our Center invites applications for the position of senior research technician with the Osteoarthritis Laboratory for Experimental !maging (OLE!), a new lab focused on the development of imaging contrast agents and therapies for osteoarthritis (OA).
The lab employs unconventional approaches to further the understanding of pathological changes that lead to knee OA. Our goal is to develop technology for in-vivo detection of these changes, allowing for earlier intervention and treatment. This role offer the opportunity to join a collaborative and innovative team, with the potential to make significant contributions to the field.
OLE! draws on the resources of the radiology department at NYU Langone Health, is affiliated with the Tech4Health Institute, and has funding support from the National Institutes of Health (NIH).
- Conduct research on biomedical imaging for musculoskeletal diseases.
- Design and perform experiments to validate new molecular biomarkers for the musculoskeletal system.
- Assist with preparation, storage, and analysis of biological samples from humans and animals.
- Collaborate with researchers to understand experimental needs.
- Manage laboratory operations and ensure adherence to safety protocols.
- Care for and handle animal models.
- Maintain accurate records and keep the lab well-equipped.
- Stay up to date on the latest scientific advances.
- Bachelor’s degree in biotechnology, biochemistry, biomedicine or a related field.
- Proven experience as a laboratory technician.
- Strong knowledge of current trends in biochemistry, animal models, and musculoskeletal tissue culture.
- Excellent teamwork skills.
- Excellent written and verbal communication skills.
- Experience handling animal models and performing related procedures.
- Expertise in cell culture and immunological assays.
- Proficiency in techniques like qPCR, western blot, and flow cytometry.
- Experience with microscopy and immunofluorescence imaging.
- Solid foundation in biochemistry and biology.
- Ability to work independently and think critically.
- Comfort with handling hazardous materials.
- In-depth understanding of QHSE management systems and laboratory best practices.
- A keen eye for detail.
- Strong analytical skills.
CAI2R (pronounced care) comprises approximately 150 full-time personnel dedicated to imaging research, development, and clinical translation. Our team is diverse and highly collaborative. We work in interdisciplinary, matrixed teams that include engineers, scientists, clinicians, technologists, and industry experts.
Joining our team means becoming part of a diverse community that values cross-pollination of ideas, celebrates creativity, and nurtures an environment conducive to breakthrough innovations.
Learn more about our mission, our research, and our team.
The Center for Advanced Imaging Innovation and Research (CAI2R) is supported by the NIH and operated by the Department of Radiology at NYU Langone Health.
Learn more about our research facilities.
The salary range for this position is $53,200-$66,780 annually, depending on qualifications and experience. NYU Langone offers competitive benefits.
NYU Langone is an equal opportunity employer. We are committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, or disability.
To apply, point your browser to the corresponding post on NYU Langone’s job portal, click Apply Now, and follow the prompts. We look forward to hearing from you.
PTOA is affecting more people earlier but medicine cannot predict who. The National Institute of Arthritis and Musculoskeletal and Skin Diseases is funding NYU Grossman School of Medicine to create an advance warning.
A team of scientists is using a battery of imaging methods to visualize cells, tissues, and joints in a quest for early noninvasive imaging biomarkers of PTOA.